APA (7th ed.) Citation

H, Z., X, Y., Y, D., J, Z., G, W., X, W., . . . S, C. (2016). MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2. Oncotarget, 7(33), 53254. https://doi.org/10.18632/oncotarget.10736

Chicago Style (17th ed.) Citation

H, Zhao, et al. "MiR-770-5p Inhibits Cisplatin Chemoresistance in Human Ovarian Cancer by Targeting ERCC2." Oncotarget 7, no. 33 (2016): 53254. https://doi.org/10.18632/oncotarget.10736.

MLA (9th ed.) Citation

H, Zhao, et al. "MiR-770-5p Inhibits Cisplatin Chemoresistance in Human Ovarian Cancer by Targeting ERCC2." Oncotarget, vol. 7, no. 33, 2016, p. 53254, https://doi.org/10.18632/oncotarget.10736.